Skin and Subcutaneous Tissue Bacterial Infections Clinical Trial
Official title:
A Phase 3 Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of IV to Oral 6-Day TR-701 Free Acid and IV to Oral 10-Day Linezolid for the Treatment of ABSSSI
This is a randomized, double-blind, double-dummy, multicenter, global Phase 3 study of IV to
oral TR-701 FA 200 mg once daily for 6 days versus IV to oral Zyvox® (linezolid) 600 mg every
12 hours for 10 days for the treatment of ABSSSI in adults. Patients are to start treatment
with at least 2 IV doses and may receive IV therapy for the entire treatment duration.
Approximately 100 to 140 sites globally will participate in this study. Patients with an
ABSSSI caused by suspected or documented gram positive pathogen(s) at baseline will be
randomized 1:1 to study treatment.
The primary objective is to determine the noninferiority (NI) in the early clinical response rate of intravenous (IV) to oral 6 day TR-701 free acid (FA) compared with that of IV to oral 10-day linezolid treatment at 48-72 hours after the first infusion of study drug in the intent-to-treat (ITT) analysis set in patients with acute bacterial skin and skin structure infections (ABSSSI). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT02572791 -
Staph Household Intervention for Eradication (SHINE)
|
Phase 4 | |
Completed |
NCT01984684 -
Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections
|
Phase 3 | |
Completed |
NCT02796716 -
Study of Accuracy of New Diagnostic Technology to Guide Rapid Antibiotic Treatment for Serious Infections
|
N/A | |
Completed |
NCT01283581 -
A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections
|
Phase 2 | |
Completed |
NCT01519492 -
A Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to Staphylococci
|
Phase 2 | |
Completed |
NCT02060513 -
Study of Accuracy of New Diagnostic Technology to Determine Guide Rapid Antibiotic Treatment for Serious Infections
|
N/A | |
Completed |
NCT01170221 -
TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.
|
Phase 3 | |
Completed |
NCT01811732 -
Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections
|
Phase 3 | |
Completed |
NCT03964493 -
TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection
|
Phase 2 |